Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 5, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 10, 2026
OfficerTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001989533-26-000011
Filed / recorded
Mar 10, 2026, 1:25 AM UTC
Added to OQRO
Oct 6, 2026, 7:59 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Jazz Pharmaceuticals plc
Issuer CIK
1232524
Ticker
JAZZ
Reporting person
Mary Elizabeth Henderson
Relationship
Officer
Officer title
SVP, Technical Operations
Security
Ordinary Shares
Table
Non-derivative (Table I)
Transaction date
Mar 5, 2026
Transaction code
F
Shares / units
1,394
Price per share
$186.75
Acquired / disposed
Disposed (D)
Shares owned after
27,334
Ownership form
Direct
Amendment
No
Footnotes from the filing
Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $186.1633 to $186.7558. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.